Medical Events in Amsterdam
World EPA Congress
World EPA Congress sets the global agenda for healthcare evidence, pricing and access
The World EPA Congress is recognized as a world-leading platform dedicated to healthcare evidence, pricing, and access. At a time when healthcare systems are under growing pressure from rising costs, demographic change, and rapid innovation, the congress brings clarity to some of the most complex questions facing the industry today. It serves as a meeting point for decision-makers who shape how medicines and therapies reach patients across global markets.
Focused on evidence-driven decision-making, the World EPA Congress connects science, policy, and strategy. It addresses the full spectrum of challenges surrounding market access and reimbursement, while keeping patient outcomes at the center of discussion. By combining strategic insight with practical expertise, the congress helps organizations navigate an increasingly demanding healthcare environment.
More than a conference, the World EPA Congress functions as a working forum for alignment between stakeholders who influence healthcare value.
A comprehensive focus on market access, pricing and reimbursement
One of the defining strengths of the World EPA Congress is its holistic approach. The event covers the full lifecycle of healthcare evidence and access, reflecting how interconnected these topics have become. Discussions move beyond theory and focus on how pricing and reimbursement decisions are made in real-world settings.
Core areas of focus include:
Market access strategy across global and regional markets
Pricing models and value-based approaches
Reimbursement pathways and payer expectations
Health technology assessments and decision frameworks
These themes are explored through practical case studies, expert panels, and strategic sessions. Participants gain insight into how evidence is evaluated, how value is demonstrated, and how access strategies can be adapted to diverse healthcare systems.
By addressing both mature and emerging markets, the congress offers a truly global perspective.
Advancing healthcare through evidence and outcomes research
Evidence lies at the heart of sustainable healthcare decisions, and the World EPA Congress places strong emphasis on its generation and application. Health economics and outcomes research play a critical role in demonstrating value, informing policy, and supporting patient-centered care.
Key topics explored include:
Real-world evidence and its role in decision-making
Health economics models supporting value demonstration
Outcomes research aligned with payer and patient needs
These discussions highlight how robust data can bridge the gap between innovation and access. By aligning clinical, economic, and real-world perspectives, stakeholders can better support informed, transparent decisions that benefit healthcare systems and patients alike.
Addressing rare diseases and specialized healthcare challenges
Rare diseases represent one of the most complex areas of modern healthcare, and the World EPA Congress dedicates focused attention to this field. The challenges of limited patient populations, high development costs, and evolving regulatory expectations require tailored approaches to pricing and access.
The congress provides a platform for dialogue on:
Innovative access models for rare and orphan diseases
Evidence generation in small populations
Collaboration between manufacturers, payers, and patient groups
These conversations recognize that traditional frameworks often fall short when applied to rare diseases. By sharing experience and best practices, participants contribute to more flexible, patient-focused solutions.
Connecting solution providers with healthcare decision-makers
With more than 120 leading solution providers participating, the World EPA Congress offers direct access to expertise across the healthcare value chain. These organizations support operational excellence in areas such as evidence generation, market access execution, pricing strategy, and data analytics.
Participants benefit from engaging with providers specializing in:
Evidence and data solutions
Market access consulting and implementation
Pricing and reimbursement analytics
Rare disease strategy and support
This ecosystem allows attendees to identify partners who can help translate strategy into execution. The emphasis is not only on ideas, but on actionable solutions that deliver measurable impact.
A global forum shaping the future of healthcare access
The World EPA Congress stands out for its ability to bring together diverse perspectives in a structured and collaborative environment. Industry leaders, policymakers, payers, researchers, and solution providers engage in open dialogue aimed at improving healthcare access while ensuring system sustainability.
By combining thought leadership with practical expertise, the congress helps shape future standards in evidence, pricing, and access. It reinforces the importance of collaboration in a landscape where no single stakeholder can address challenges alone.
For professionals seeking to stay ahead of evolving healthcare expectations, the World EPA Congress remains an essential event a place where evidence meets strategy, access meets innovation, and the future of global healthcare takes form.
DENTAL EXPO NETHERLANDS
Dental Expo serves as a vital connection point between dental care professionals and the future trajectory of the dental industry. Its mission is to unite and inspire individuals within the field, creating an invaluable platform where industry experts converge. This comprehensive event is where the entire dental market comes together, offering opportunities to reconnect with familiar faces or forge new business relationships in a relaxed, informal setting.
The exhibition stands out not only for its networking potential but also for its rich program of seminars and masterclasses led by experts. These sessions provide a deep dive into the latest advancements and emerging trends in dental care, positioning Dental Expo as an essential event for anyone seeking to stay at the forefront of professional knowledge and industry developments.
Through its engaging format and diverse offerings, Dental Expo fosters a collaborative environment that encourages learning and professional growth, making it a cornerstone event for those dedicated to advancing their expertise and expanding their connections within the dental community.
PHARMAP
PHARMAP – Europe’s Premier Pharmaceutical Manufacturing & Packaging Congress is an exclusive annual gathering designed for senior professionals across the pharmaceutical industry. Over the years, PHARMAP has established itself as a key closed-door event in Europe, bringing together more than 300 decision-makers from pharmaceutical companies, contract manufacturing organizations (CMOs), and service providers. The congress offers a unique environment where industry leaders can exchange knowledge, explore business opportunities, and gain actionable insights in a focused, professional setting.
Unlike larger, public trade shows, PHARMAP’s format emphasizes high-quality interactions. Attendees engage directly with peers and experts in structured sessions that balance learning and networking. This targeted approach ensures that every participant can connect with the right people and gain information relevant to their specific role in the value chain.
Knowledge Sharing Across the Value Chain
At PHARMAP, knowledge transfer is at the core of the experience. The congress features case study presentations, panel discussions, roundtables, and B2B meetings, all designed to provide attendees with practical insights that can be applied immediately. Topics cover a wide spectrum of pharmaceutical manufacturing and packaging challenges, including regulatory compliance, process optimization, innovation in drug delivery, and sustainable packaging solutions.
Key areas of focus include:
Best practices in pharmaceutical production and packaging
Emerging technologies for drug formulation and delivery
Quality management systems and regulatory updates
Strategies for collaboration with CMOs and service providers
Sustainable and cost-efficient packaging solutions
This breadth ensures that participants from different segments of the industry leave with a comprehensive understanding of trends, challenges, and innovations shaping the sector.
Networking with Industry Decision-Makers
PHARMAP provides a highly curated networking environment. By focusing on senior professionals and decision-makers, the congress allows for meaningful conversations that often lead to strategic partnerships, collaborations, and new business opportunities. Participants have the chance to benchmark approaches, explore new technologies, and exchange experiences with peers who face similar operational and strategic challenges.
Networking opportunities at PHARMAP include:
B2B meetings that connect suppliers with pharmaceutical companies and CMOs
Roundtables for interactive discussions on industry trends and challenges
Panel sessions where experts share insights and encourage dialogue
Informal networking during breaks and dedicated social events
These interactions create a professional yet collaborative atmosphere, ensuring that relationships formed at the congress extend beyond the event itself.
A Focused Platform for Strategic Insights
What sets PHARMAP apart is its emphasis on relevance and quality over quantity. Every session, discussion, and meeting is curated to ensure participants gain insights that are immediately useful for decision-making and operational improvement. Case studies often illustrate real-world applications, offering practical lessons that go beyond theoretical knowledge.
Attendees leave PHARMAP equipped with:
Strategies to enhance production efficiency and quality
Knowledge of emerging technologies and innovations
Insights into regulatory trends and compliance challenges
Connections with potential partners, suppliers, and collaborators
Driving the Future of Pharmaceutical Manufacturing
PHARMAP is more than a congress; it is a strategic platform where the European pharmaceutical community comes together to shape the future of manufacturing and packaging. By combining knowledge-sharing, networking, and business development in a single high-level environment, PHARMAP enables professionals to navigate complex industry challenges while seizing opportunities for growth and innovation.
For executives, technical experts, and decision-makers involved in pharmaceutical production and packaging, PHARMAP offers a rare opportunity to connect, learn, and collaborate in a focused, results-oriented setting. It is a must-attend event for those looking to stay ahead in an industry defined by rapid technological advancement, regulatory evolution, and competitive pressures.
World Drug Safety Congress Europe
World Drug Safety Congress Europe – Advancing Pharmacovigilance and Patient Safety
The World Drug Safety Congress Europe, held annually at the RAI Amsterdam, is one of the most influential events dedicated to drug safety, pharmacovigilance, and risk management in the pharmaceutical and biotechnology sectors. Organized by Terrapinn Holdings Ltd., the congress has established itself as a central hub for professionals across pharmacy, biotech, and medical technology to explore the latest developments, innovations, and best practices in ensuring patient safety. With its comprehensive program, the event attracts regulatory experts, industry leaders, academic researchers, and technology innovators from around the globe.
Amsterdam, renowned for its status as a center for medical research and development, provides the perfect backdrop for the congress. The RAI Amsterdam offers modern facilities, excellent accessibility, and a professional environment that supports large-scale exhibitions, interactive workshops, and high-level networking opportunities, making it an ideal venue for this international gathering.
Exploring cutting-edge innovations in drug safety
At the heart of the World Drug Safety Congress Europe is a focus on practical and innovative solutions for pharmacovigilance. Attendees gain exposure to emerging tools and strategies that enhance patient safety and optimize operational efficiency, including:
Artificial intelligence and automation for risk assessment and signal detection
Natural language processing systems for analyzing safety reports and literature
Advanced monitoring platforms for real-time pharmacovigilance
Cost-effective AI applications that streamline regulatory compliance
Data analytics tools for evaluating safety trends and generating actionable insights
By showcasing these solutions, the congress helps professionals implement smarter, faster, and more reliable safety protocols in their organizations, ensuring that pharmacovigilance keeps pace with the rapidly evolving healthcare landscape.
Comprehensive education and expert-led sessions
A distinguishing feature of the congress is its combination of high-level education and hands-on practical learning. The program includes:
Interactive workshops and case studies demonstrating real-world applications of drug safety strategies
Panel discussions addressing regulatory challenges, quality control, and patient-centric approaches
Seminars on advanced analytical techniques and emerging technologies in pharmacovigilance
Debates on the ethical and operational implications of AI and digital health tools in safety monitoring
These sessions provide participants with actionable knowledge, enabling them to enhance their organizations’ safety frameworks and stay at the forefront of regulatory and technological advancements.
Networking and interdisciplinary collaboration
The congress brings together a diverse range of stakeholders, including pharmaceutical companies, biotechnology firms, regulatory agencies, academic institutions, and technology providers. This diversity encourages cross-industry collaboration, knowledge exchange, and the formation of strategic partnerships. Whether during networking sessions, informal meetups, or workshops, attendees have ample opportunity to connect with leading experts and decision-makers, fostering a community dedicated to improving drug safety worldwide.
Global significance and strategic impact
As part of a global series of drug safety congresses, the European edition underscores the international importance of pharmacovigilance. By addressing challenges such as compliance, signal detection, and patient-centered monitoring, the event provides a platform for sharing knowledge and implementing solutions that have a worldwide impact. The congress covers the full spectrum of drug safety, from digital health tools and safety databases to advanced analytics and automation, making it indispensable for professionals seeking the latest insights and strategies.
Driving progress in pharmacovigilance
Ultimately, the World Drug Safety Congress Europe combines knowledge, innovation, and practical application to deliver a comprehensive experience for all attendees. Participants leave with:
Exposure to cutting-edge technologies that improve efficiency and compliance
Insights into global regulatory standards and emerging industry trends
Opportunities to collaborate with experts from diverse sectors
Practical tools and strategies to enhance patient safety
In conclusion, the congress is an essential event for pharmaceutical, biotechnology, and healthcare professionals who are committed to advancing drug safety and improving outcomes for patients worldwide. By uniting innovation, education, and international networking, it remains a cornerstone for anyone involved in pharmacovigilance and regulatory science.
Veterinary Sport Horse Congress
The Veterinary Sport Horse Congress, held in Amsterdam, is a leading international event that attracts over 400 equine veterinarians from 32 countries. It has become one of the most important gatherings for professionals working in the field of sport horse medicine and management. With a focus on the health and performance of sport horses, the congress offers a comprehensive program designed to address both the medical and management aspects of equine care.
Internationally renowned speakers from various corners of the equine world will present the latest research, techniques, and innovations in sport horse veterinary care. Topics range from injury prevention and treatment, rehabilitation strategies, nutritional management, to cutting-edge diagnostic and therapeutic techniques. These sessions are crafted to equip veterinarians with the knowledge and skills necessary to handle the complex needs of sport horses in disciplines such as dressage, show jumping, eventing, and racing.
Beyond the main two-day event, the congress also features an optional practical pre-congress day. This additional day allows attendees to participate in hands-on workshops and demonstrations, giving them the chance to refine their practical skills and learn new techniques in real-world scenarios. This is particularly valuable for professionals looking to gain more experience with specific procedures or treatment protocols.
The congress serves as an invaluable networking platform, where veterinarians can engage in meaningful discussions, collaborate with international colleagues, and establish connections that can lead to future partnerships. It is a prime opportunity for equine practitioners to stay up to date with the latest trends in sport horse medicine, share case studies, and discuss challenges and solutions in the care of elite equine athletes.
This event has earned a reputation for its high-quality content, diverse range of topics, and the caliber of its speakers, making it an essential experience for anyone in the field of sport horse veterinary medicine. Whether you're looking to enhance your clinical knowledge, gain hands-on experience, or connect with a global community of experts, the Veterinary Sport Horse Congress in Amsterdam is the place to be.
